Navigation Links
MDC Partners Launches Integrated Healthcare Marketing Platform With Acquisition of Majority Stake in Concentric Pharma Advertising
Date:9/16/2011

NEW YORK, Sept. 16, 2011 /PRNewswire/ -- MDC Partners (www.mdc-partners.com) announced today that they have acquired a majority stake in leading healthcare and pharma advertising and marketing agency, Concentric Pharma Advertising ("Concentric") (www.concentricpharma.com).  The partnership with Concentric marks MDC Partner's first significant investment in the rapidly growing healthcare marketing sector and positions MDC to offer an integrated healthcare marketing platform that is unique within the industry.  

Named 2011 Agency of the Year by the Med Ad News, Concentric is a full-service, independent, healthcare advertising and promotion agency with a focus on the specialty pharma sector.  Concentric has built a top tier client list that includes Alcon Labs, Allergan, Bayer HealthCare, Discovery Labs, Genentech, LEO Pharma, MAP Pharma, Novartis, Oceana Therapeutics, Pfizer, Roche, Salix, and Wyeth.  Concentric was recently named agency of record for the rheumatology indication of Enbrel from Amgen and Pfizer Inc.

"MDC's approach is to disrupt the status quo by bringing better, more modern sets of solutions to clients – and this is exactly what the deal with Concentric allows us to do in healthcare," said Miles Nadal, Chairman and CEO of MDC Partners.  "Clients in this sector increasingly are seeking to go beyond outdated one-size-fits-all approaches and find true evolution.  The partnership between Concentric and MDC Partners launches a network model that integrates sophisticated multichannel strategies from the most cutting-edge agencies in the world and applies them to the needs of healthcare - using Concentric as the knowledge portal into the industry. This truly collaborative model is unique and is a meticulously choreographed multichannel machine that will revolutionize the promotional offering for our pharmaceutical cli
'/>"/>

SOURCE MDC Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
6. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
7. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... MEETING, Pa. , Sept. 22, 2014 /PRNewswire/ ... announced today it has initiated a phase I ... trial will evaluate the safety, tolerability, and immunogenicity ... 6 (HPV-6), which causes most aerodigestive cancers. ... nose, throat, vocal cords, and parts of the ...
(Date:9/22/2014)... SAN DIEGO , Sept. 22, 2014 Arena ... the company is scheduled to present a corporate overview ... conference on Friday, September 26, 2014, at 11:30 a.m. ... Broadway Hotel in New York City ... presentation will be available under the investor relations section ...
(Date:9/22/2014)... Sept. 22, 2014 Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... has been appointed President and Chief Executive Officer, effective ... has stepped down from his executive and Board roles ... through the first quarter of 2016.  ...
Breaking Medicine Technology:Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5
(Date:9/22/2014)... Angeles, CA (PRWEB) September 22, 2014 ... life insurance industry is now easier using the Quotes ... who are trying to local universal life insurance pricing ... The adult coverage plans that are easily viewed when ... that underwrite specific lengths of coverage. The plan data ...
(Date:9/22/2014)... Manhattan residents who suffer with hip ... hip , which could be bursitis now have a ... now offered at New York Dynamic Neuromuscular Rehabilitation Center. ... occurs when the trochanteric bursa becomes irritated or inflamed. ... between the iliotibial band and the greater trochanter. Most ...
(Date:9/22/2014)... seems futuristic, if not impossible. But with a ... researchers at University of California, San Diego School ... an entire, functional eye a reality. , "A ... for vision restoration," said Jeffrey Goldberg, MD, PhD, ... at University of Pittsburg Medical Center and Boston ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 This Flash ... on stakeholder management needs for the Prostate Cancer market. ... Experts on stakeholder strategies for any launching Prostate Cancer ... of differentiation within an increasingly crowded market , ... The impact of identifying community-based thought leaders and stakeholders ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 The ... the nation’s leading nonprofit authority on the use ... information exchange, announced findings from its recent industry ... Plan Identifier (HPID) within electronic transactions adopted under ... WEDI conducted the survey from August 20 to ...
Breaking Medicine News(10 mins):Health News:Universal Life Insurance Prices for Adults Added to National Insurer Portal Online 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:Looking ahead: Whole eye transplant under development 2Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3
... aiding joint inflammations in conditions like // arthritis. ... of the immune cells to secrete chemicals that will ... to arthritis. The enzyme cathepsin G attracts accumulation of ... tissue and cartilage in joints leading to the inflammatory ...
... a common water pollutant called arsenic may not be the ... a gene called CYT19 in people, particularly in children, that ... arsenic. ,Arsenic exposure had long been associated with health ... problems, and neurological disorders. It can enter the body through ...
... could run using a pollution free energy source.// ... working towards this solution to look at making hydrogen fuel ... hydrogen would reacts with oxygen to produce water and energy. ... would be pollution free. A similar mechanism is already followed ...
... had lead to inability to curbing of inflammatory cells// ... likewise. Researchers from Oregon Health & Science University have ... the low immune problem that leads to progress of ... disease of the central nervous system. There is no ...
... Prostate cancer is the commonest cancer effecting men. Benefits ... watermelon, papaya and pink grapefruit( most lycopene in processed ... known for sometime in preventing the aging process ... It is now being looked at for preventing and ...
... People suffering from diabetes type 1 or type 2 ... tract infections and skin infections. ,Some other ... kidney damage, nerve damage, eye problems that can lead ... a major risk factor for incidence of diabetes of ...
Cached Medicine News:Health News:Pollution Free Hydrogen based fuel for Energy 2Health News:Pollution Free Hydrogen based fuel for Energy 3
Designed to meet the requirements of reagent grade water for routine analysis....
... L/min of Type I ultrapure water, , ... Plus System is designed to provide the ... pretreated by reverse osmosis, distillation or deionization. ... quality which exceeds Type I ASTM/CAP/NCCLS specifications.,The ...
... Basic Laboratory Needs, Synergy systems produce ultrapure water ... 1 to 1.2 L/min to meet the basic ... incorporates a dual-wavelength UV lamp (185 nm and ... of organic contaminants (< 5 ppb TOC when ...
... Compact System Produces Type I Water Directly from ... designed for scientists who need 5 to 15 ... not have easy access to acceptable quality pretreated ... 0.6 L/min of ultrapure (Type I) water on ...
Medicine Products: